Both in Pharmaceuticals
Serina Therapeutics vs Biomea Fusion
Over the past year SER returned −61.2% and BMEA returned −53.0%; their daily moves had a correlation of 0.07.
SER −61.2% BMEA −53.0%Growth of $1, one year, split-adjusted
| Metric | SER | BMEA |
|---|---|---|
| Price | $1.94 | $0.6395 |
| Market cap | $49.3M | $46.4M |
| Today | +2.65% | +2.68% |
| 1 month | −0.5% | −50.8% |
| 6 months | +6.8% | −53.3% |
| Year to date | +1.4% | −48.4% |
| 1 year | −58.8% | −53.3% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $19.9M | $34.8M |
| Dividend yield | — | — |
| Volatility (60d) | 78.0% | 121.5% |
| Short % of float | 0.6% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).